English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/167013
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorGómez-SanJuan, Asier-
dc.contributor.authorGamo, Ana María-
dc.contributor.authorDelang, Leen-
dc.contributor.authorPérez-Sánchez, Alfonso-
dc.contributor.authorAmrun, S. N.-
dc.contributor.authorAbdelnabi, R.-
dc.contributor.authorJacobs, S.-
dc.contributor.authorPriego, Eva María-
dc.contributor.authorCamarasa Rius, María José-
dc.contributor.authorJochmans, D.-
dc.contributor.authorLeyssen, Pieter-
dc.contributor.authorNg, L. F. P.-
dc.contributor.authorQuerat, Guilles-
dc.contributor.authorNeyts, J.-
dc.contributor.authorPeréz-Pérez, María-Jesús-
dc.date.accessioned2018-06-26T10:41:12Z-
dc.date.available2018-06-26T10:41:12Z-
dc.date.issued2018-
dc.identifierdoi: 10.1021/acsinfecdis.7b00219-
dc.identifierissn: 2373-8227-
dc.identifier.citationACS Infectious Diseases 4: 605-619 (2018)-
dc.identifier.urihttp://hdl.handle.net/10261/167013-
dc.description.abstractThe re-emergence of chikungunya virus (CHIKV) is a serious global health threat. CHIKV is an alphavirus that is transmitted to humans by Aedes mosquitoes; therefore, their wide distribution significantly contributes to the globalization of the disease. Unfortunately, no effective antiviral drugs are available. We have identified a series of 3-aryl-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones as selective inhibitors of CHIKV replication. New series of compounds have now been synthesized with the aim to improve their physicochemical properties and to potentiate the inhibitory activity against different CHIKV strains. Among these newly synthesized compounds modified at position 3 of the aryl ring, tetrahydropyranyl and N-t-butylpiperidine carboxamide derivatives have shown to elicit potent antiviral activity against different clinically relevant CHIKV isolates with 50% effective concentration (EC) values ranging from 0.30 to 4.5 μM in Vero cells, as well as anti-CHIKV activity in human skin fibroblasts (EC = 0.1 μM), a clinically relevant cell system for CHIKV infection.-
dc.description.sponsorshipWe thank Caroline Collard and Nick Verstraeten for their excellent technical assistance in the acquisition of the antiviral data. This work has been supported by grants from MINECO/ FEDER SAF2015-64629-C2-1-R and by European Union FP7 Program under SILVER grant agreement no. 260644.-
dc.publisherAmerican Chemical Society-
dc.relationeu-repo/grantAgreement/EC/FP7/260644-
dc.relationMINECO/ICTI2013-2016/SAF2015-64629-C2-1-R-
dc.relation.isversionofPosprint-
dc.rightsopenAccess-
dc.subjectChikungunya virus-
dc.subjectPhysicochemical properties-
dc.subjectTriazolopyrimidines-
dc.titleInhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d] pyrimidin-7(6 H)-ones-
dc.typeArtículo-
dc.relation.publisherversionhttp://dx.doi.org/10.1021/acsinfecdis.7b00219-
dc.date.updated2018-06-26T10:41:13Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderEuropean Commission-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
Appears in Collections:(IQM) Artículos
Files in This Item:
File Description SizeFormat 
ACS Infect Dis 2018.pdfArtículo principal1,26 MBAdobe PDFThumbnail
View/Open
Supp Info ACS Infect Dis.pdfSupporting info 603,72 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.